ResearcherNorthwest Women's and Children's HospitalActive in the last 2 years

Sen Qiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5982-1386; OpenAlex author ID A5064115375. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 3

Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcinoma proliferation. Co-author DOI 10.1002/cnr2.2108 ↗
Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. Co-author DOI 10.1016/j.tice.2022.101867 ↗
Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. Co-author DOI 10.1016/j.jpba.2021.114339 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hongmei Wang · 1 shared paper, 2024 · strength 0.36
- Paper Genetic and immune identification and functional analysis of TRPM8 as a potential biomarker for pancreatic adenocarcino… DOI 10.1002/cnr2.2108 ↗
Huijie Gao · 2 shared papers, 2021–2022 · strength 0.25
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339 ↗
Litao Zhang · 2 shared papers, 2021–2022 · strength 0.25
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339 ↗
Yuntao Zhang · 2 shared papers, 2021–2022 · strength 0.25
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339 ↗
Qiang Ren · 2 shared papers, 2021–2022 · strength 0.25
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339 ↗
Wei Qin · 2 shared papers, 2021–2022 · strength 0.25
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339 ↗
Lingxin Meng · 2 shared papers, 2021–2022 · strength 0.25
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗
- Paper Exploring the sulfate patterns of chondroitin sulfate/dermatan sulfate and keratan sulfate in human pancreatic cancer. DOI 10.1016/j.jpba.2021.114339 ↗
Jing Zhang · 1 shared paper, 2022 · strength 0.13
- Paper Osteoglycin (OGN) promotes tumorigenesis of pancreatic cancer cell via targeting ID4. DOI 10.1016/j.tice.2022.101867 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.